99 related articles for article (PubMed ID: 32842856)
21. [Extension of the target age range of mammography screening programme and governance of mammography practice in the Emilia-Romagna Region (Northern Italy)].
Sassoli de Bianchi P; Ravaioli A; Ferretti S; Finarelli AC; Giannini A; Naldoni C; Sanna P; Bucchi L
Epidemiol Prev; 2017; 41(1):38-45. PubMed ID: 28322527
[TBL] [Abstract][Full Text] [Related]
22. Evidence of interval cancer proportional incidence and review from mammography screening programs in Italy.
Ciatto S; Bernardi D; Caumo F
Tumori; 2011; 97(4):419-22. PubMed ID: 21989427
[TBL] [Abstract][Full Text] [Related]
23. [The offer of organized mammography screening from 45 to 74 years of age and open issues in the age group 45-54 years].
Paci E
Epidemiol Prev; 2023; 47(3):187-191. PubMed ID: 37337942
[TBL] [Abstract][Full Text] [Related]
24. Breast Cancer Detection Rate, Incidence, Prevalence and Interval Cancer-related Mammography Screening Times among Thai Women.
Sripaiboonkij N; Thinkamrop B; Promthet S; Kannawat C; Tangcharoensathien V; Ansusing T; Rattanamongkolgul S
Asian Pac J Cancer Prev; 2016; 17(8):4137-41. PubMed ID: 27644674
[TBL] [Abstract][Full Text] [Related]
25. Interval cancer rates in the Irish national breast screening programme.
O'Brien KM; Dwane F; Kelleher T; Sharp L; Comber H
J Med Screen; 2015 Sep; 22(3):136-43. PubMed ID: 25917389
[TBL] [Abstract][Full Text] [Related]
26. Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey.
Sardanelli F; Aase HS; Álvarez M; Azavedo E; Baarslag HJ; Balleyguier C; Baltzer PA; Beslagic V; Bick U; Bogdanovic-Stojanovic D; Briediene R; Brkljacic B; Camps Herrero J; Colin C; Cornford E; Danes J; de Geer G; Esen G; Evans A; Fuchsjaeger MH; Gilbert FJ; Graf O; Hargaden G; Helbich TH; Heywang-Köbrunner SH; Ivanov V; Jónsson Á; Kuhl CK; Lisencu EC; Luczynska E; Mann RM; Marques JC; Martincich L; Mortier M; Müller-Schimpfle M; Ormandi K; Panizza P; Pediconi F; Pijnappel RM; Pinker K; Rissanen T; Rotaru N; Saguatti G; Sella T; Slobodníková J; Talk M; Taourel P; Trimboli RM; Vejborg I; Vourtsis A; Forrai G
Eur Radiol; 2017 Jul; 27(7):2737-2743. PubMed ID: 27807699
[TBL] [Abstract][Full Text] [Related]
27. Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden.
Bordás P; Jonsson H; Nyström L; Lenner P
J Med Screen; 2009; 16(1):39-45. PubMed ID: 19349530
[TBL] [Abstract][Full Text] [Related]
28. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
29. Analysis of interval cancers observed in an Italian mammography screening programme (2000-2006).
Caumo F; Vecchiato F; Pellegrini M; Vettorazzi M; Ciatto S; Montemezzi S
Radiol Med; 2009 Sep; 114(6):907-14. PubMed ID: 19551342
[TBL] [Abstract][Full Text] [Related]
30. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
31. Biennial screening mammography: How many women ask for more? Estimate of the interval mammogram rate in an organised population-based screening programme.
Carbonaro LA; Rizzo SS; Schiaffino S; Pisani Mainini A; Berger N; Trimboli RM; Sardanelli F
Radiol Med; 2021 Feb; 126(2):200-205. PubMed ID: 32577906
[TBL] [Abstract][Full Text] [Related]
32. [Breast cancer screening in urban Beijing, 2014-2019].
Yang L; Zhang X; Liu S; Li HC; Zhang Q; Wang N; Ji JF
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Sep; 54(9):974-980. PubMed ID: 32907288
[No Abstract] [Full Text] [Related]
33. Introduction of organised mammography screening in Tyrol: results of a one-year pilot phase.
Oberaigner W; Buchberger W; Frede T; Daniaux M; Knapp R; Marth C; Siebert U
BMC Public Health; 2011 Feb; 11():91. PubMed ID: 21306614
[TBL] [Abstract][Full Text] [Related]
34. Problems, solutions, and perspectives in the evaluation of interval cancers in Italian mammography screening programmes: a position paper from the Italian group for mammography screening (GISMa).
Bucchi L; Frigerio A; Zorzi M; Fedato C; Angiolucci G; Bernardi D; Campari C; Crocetti E; Ferretti S; Giorgi D; Marchisio F; Morrone D; Naldoni C; Petrella M; Ponti A; Ravaioli A; Saguatti G; Santini D; Sassoli de Bianchi P; Serafini M; Vergini V; Giordano L
Epidemiol Prev; 2015; 39(3 Suppl 1):52-7. PubMed ID: 26405777
[TBL] [Abstract][Full Text] [Related]
35. Annual mammography at age 45-49 years and biennial mammography at age 50-69 years: comparing performance measures in an organised screening setting.
Bucchi L; Ravaioli A; Baldacchini F; Giuliani O; Mancini S; Vattiato R; Falcini F; Giorgi Rossi P; Campari C; Canuti D; Di Felice E; Sassoli de Bianchi P; Ferretti S; Bertozzi N;
Eur Radiol; 2019 Oct; 29(10):5517-5527. PubMed ID: 30887204
[TBL] [Abstract][Full Text] [Related]
36. [Mammography breast cancer screening in Italy: 2010 survey].
Giorgi D; Giordano L; Ventura L; Frigerio A; Paci E; Zappa M
Epidemiol Prev; 2012; 36(6 Suppl 1):8-27. PubMed ID: 23293268
[TBL] [Abstract][Full Text] [Related]
37. Monitoring interval cancers in an Australian mammographic screening programme.
Kavanagh AM; Mitchell H; Farrugia H; Giles GG
J Med Screen; 1999; 6(3):139-43. PubMed ID: 10572844
[TBL] [Abstract][Full Text] [Related]
38. Supplemental MRI Screening for Women with Extremely Dense Breast Tissue.
Bakker MF; de Lange SV; Pijnappel RM; Mann RM; Peeters PHM; Monninkhof EM; Emaus MJ; Loo CE; Bisschops RHC; Lobbes MBI; de Jong MDF; Duvivier KM; Veltman J; Karssemeijer N; de Koning HJ; van Diest PJ; Mali WPTM; van den Bosch MAAJ; Veldhuis WB; van Gils CH;
N Engl J Med; 2019 Nov; 381(22):2091-2102. PubMed ID: 31774954
[TBL] [Abstract][Full Text] [Related]
39. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
40. Performance indicators evaluation of the population-based breast cancer screening programme in Northern Portugal using the European Guidelines.
Bento MJ; Gonçalves G; Aguiar A; Castro C; Veloso V; Rodrigues V
Cancer Epidemiol; 2015 Oct; 39(5):783-9. PubMed ID: 26315486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
